Advanced Biomed Inc. shares rise 5.50% intraday after Mainz Biomed launches ColoAlert® in Switzerland.

martes, 23 de septiembre de 2025, 1:03 pm ET1 min de lectura
ADVB--
Advanced Biomed Inc. rose 5.50% in intraday trading, with Mainz Biomed N.V. announcing the commercial launch of its flagship product, ColoAlert®, in Switzerland. This milestone follows several key achievements, indicating a positive development for the company.

Advanced Biomed Inc. shares rise 5.50% intraday after Mainz Biomed launches ColoAlert® in Switzerland.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios